Growth Metrics

AC Immune (ACIU) Net Margin (2015 - 2026)

AC Immune (ACIU) reported Net Margin of 1322.7% for Q1 2026, up 59942.0% year-over-year from N/an in Q1 2025, and up 68.89% on a QoQ basis from 4252.37% in Q4 2025.

AC Immune (ACIU) has 10 years of Net Margin data on file, last reported at 1322.7% in Q1 2026.

  • Quarterly Net Margin rose 59942.0% year-over-year to 1322.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1787.93% (down 160984.0% YoY) and the FY2025 annual result came in at 1971.65%, down 178520.0% from the prior year.
  • Net Margin advanced to 1322.7% in Q1 2026 per ACIU's latest filing, from 4252.37% in the prior quarter.
  • Across five years, Net Margin topped out at 21.59% in Q3 2024 and bottomed at 4252.37% in Q4 2025.
  • The 4-year median for Net Margin is 1622.43% (2025), against an average of 1759.47%.
  • Peak annual rise in Net Margin reached 169052 bps in 2025, while the deepest fall reached 286327 bps in 2025.
  • Tracing ACIU's Net Margin over 4 years: stood at 346.36% in 2022, then slumped by 301 bps to 1389.09% in 2024, then slumped by 206 bps to 4252.37% in 2025, then surged by 69 bps to 1322.7% in 2026.
  • Per Business Quant, the three latest ACIU Net Margin figures stand at 1322.7% (Q1 2026), 4252.37% (Q4 2025), and 1688.82% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 AC Immune 325.88 Mn 211.53 Mn - -1,322.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,322.70%
Dec 31, 2025 -4,252.37%
Sep 30, 2025 -1,688.82%
Jun 30, 2025 -1,622.43%
Mar 31, 2025 -1,922.12%
Dec 31, 2024 -1,389.09%
Sep 30, 2024 21.59%
Jun 30, 2024 -3,312.95%
Sep 30, 2022 -346.36%
Dec 31, 2020 -2,065.68%
Sep 30, 2020 -1,691.36%
Jun 30, 2020 -1,453.19%
Mar 31, 2020 -51.97%
Dec 31, 2019 -2,261.16%
Sep 30, 2019 827.86%
Jun 30, 2019 -1,118.40%
Mar 31, 2019 84.72%
Dec 31, 2018 -1,309.37%
Sep 30, 2018 -586.38%
Jun 30, 2018 -549.46%
Mar 31, 2018 -796.57%
Dec 31, 2017 29.74%
Sep 30, 2017 -900.00%
Jun 30, 2017 -1,025.00%
Mar 31, 2017 -471.34%
Dec 31, 2016 -314.86%
Sep 30, 2016 -607.69%
Jun 30, 2016 89.29%
Mar 31, 2016 -1,267.97%
Dec 31, 2015 -840.96%
Sep 30, 2015 82.46%